The mRNA therapeutics market offers key opportunities in developing vaccines and treatments for chronic and infectious diseases, driven by successful clinical trials and increased government and ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

Alternative splicing exhibits lineage-specific variability, with mammals and birds reaching the highest levels despite conserved intron-rich architectures, while unicellular eukaryotes and prokaryotes ...

An update from Noxopharm Ltd. ( ($AU:NOX) ) is now available. Noxopharm Limited has secured its first US patent for the Sofra™ technology ...

Since launching in 2008, the MIT Global Seed Funds (GSF) program has awarded roughly $30 million to more than 1,300 ...

Secretary of Health and Human ServicesRobert F. Kennedy, Jr.is under constant siege. The political establishment that has ...

MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company today announced the ...

Danaher Corporation ( NYSE: DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT ...

Musa Mbhele of the eThekwini Municipality has been cleared of wrongdoing by advocate Smanga Sethene. It is known that ...

Because few animals menstruate, researchers have previously studied the process by inducing a pseudo-pregnancy in regular ...

Therapeutics and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for mRNA therapeutics was valued at $7.71 billion in 2025 and is forecast to remain stable ...